Biguanide-Based Synthesis of 1,3,5-Triazine Derivatives with Anticancer Activity and 1,3,5-Triazine Incorporated Calcium Citrate Nanoparticles.
1,3,5-triazine
anticancer
calcium citrate
nanoparticles
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
15 Feb 2021
15 Feb 2021
Historique:
received:
25
01
2021
revised:
11
02
2021
accepted:
12
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
10
4
2021
Statut:
epublish
Résumé
Twelve derivatives of biguanide-derived 1,3,5-triazines, a promising class of anticancer agent, were synthesised and evaluated for their anticancer activity against two colorectal cancer cell lines-HCT116 and SW620.
Identifiants
pubmed: 33672071
pii: molecules26041028
doi: 10.3390/molecules26041028
pmc: PMC7919653
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Biguanides
0
Triazines
0
Calcium Citrate
MLM29U2X85
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Chulalongkorn University
ID : CU_GR_63_159_23_25
Organisme : Chulalongkorn University
ID : 72nd Anniversary of His Majesty King Bhumibol Adulyadej Scholarship
Organisme : Chulalongkorn University
ID : 90th Anniversary Chulalongkorn University Fund (Ratchadapiseksomphot Endowment Fund)
Références
Nanoscale Res Lett. 2013 Jul 15;8(1):321
pubmed: 23849350
J Colloid Interface Sci. 2017 Sep 15;502:59-66
pubmed: 28477470
Adv Drug Deliv Rev. 2011 Mar 18;63(3):131-5
pubmed: 20304019
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Bioorg Med Chem Lett. 2013 Dec 15;23(24):6886-9
pubmed: 24153206
Clin Cancer Res. 2011 May 15;17(10):3193-203
pubmed: 21325073
Molecules. 2018 Aug 06;23(8):
pubmed: 30082588
ACS Omega. 2020 Mar 27;5(13):7418-7423
pubmed: 32280883
ACS Omega. 2019 Sep 03;4(12):14860-14867
pubmed: 31552325
Molecules. 2018 Jul 03;23(7):
pubmed: 29970833
Chem Asian J. 2015 Jan;10(1):166-71
pubmed: 25377905
Bioorg Med Chem Lett. 2016 Apr 15;26(8):2030-4
pubmed: 26965855
J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:1-7
pubmed: 25464019
Toxicol Lett. 2013 Oct 24;222(2):139-45
pubmed: 23916687
Eur J Med Chem. 2016 Jul 19;117:59-69
pubmed: 27089212
J Control Release. 2011 Aug 10;153(3):198-205
pubmed: 21663778
Org Biomol Chem. 2018 Aug 22;16(33):6140-6145
pubmed: 30101252
Asian Pac J Trop Med. 2012 Apr;5(4):310-4
pubmed: 22449524
Cancer Res. 2013 Mar 1;73(5):1524-35
pubmed: 23288510
Molecules. 2017 Oct 18;22(10):
pubmed: 29057810
Bioengineered. 2016 Sep 2;7(5):376-381
pubmed: 27710434
Nanoscale Res Lett. 2017 Dec;12(1):355
pubmed: 28525950
Drug Discov Today. 2017 Aug;22(8):1224-1232
pubmed: 28545838
Food Res Int. 2018 May;107:195-205
pubmed: 29580478
Colloids Surf B Biointerfaces. 2014 Nov 1;123:498-505
pubmed: 25315499
Expert Opin Drug Deliv. 2009 Mar;6(3):285-304
pubmed: 19327045
ACS Comb Sci. 2019 Jul 8;21(7):548-555
pubmed: 31180634
Bioorg Med Chem. 2013 Apr 15;21(8):2305-2313
pubmed: 23490148
J Control Release. 2015 Dec 10;219:536-547
pubmed: 26450667
Biomaterials. 2018 Sep;178:383-400
pubmed: 29759730